Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RANOLAZINE Cause Wrong technique in product usage process? 143 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Wrong technique in product usage process have been filed in association with RANOLAZINE (Ranolazine). This represents 1.5% of all adverse event reports for RANOLAZINE.

143
Reports of Wrong technique in product usage process with RANOLAZINE
1.5%
of all RANOLAZINE reports
2
Deaths
28
Hospitalizations

How Dangerous Is Wrong technique in product usage process From RANOLAZINE?

Of the 143 reports, 2 (1.4%) resulted in death, 28 (19.6%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 143 reports have been filed with the FAERS database.

What Other Side Effects Does RANOLAZINE Cause?

Death (692) Myocardial infarction (610) Stent placement (593) Chest pain (592) Angina pectoris (583) Dizziness (517) Dyspnoea (348) Cerebrovascular accident (334) Fall (299) Off label use (270)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which RANOLAZINE Alternatives Have Lower Wrong technique in product usage process Risk?

RANOLAZINE vs RAPAMUNE RANOLAZINE vs RASAGILINE RANOLAZINE vs RASBURICASE RANOLAZINE vs RAVULIZUMAB RANOLAZINE vs RAVULIZUMAB-CWVZ

Related Pages

RANOLAZINE Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process RANOLAZINE Demographics